GDS.PA Ramsay Generale De Sante

Healthcare Health Care Providers & Services Euronext Paris
8.84 EUR
Close of Nov 6, 2026
8.50 11.55
Market cap
EUR 976M
P/E
-
P/B
0.87x
ROE
-4.3%
Dividend yield
-
Fundamental score
1.8/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is GDS.PA undervalued?

Graham number

The Graham number of Ramsay Generale De Sante cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ramsay Generale De Sante fundamental analysis

6 of 11 checks passed

ROE 1/2

ROE in an average range (4.02%) suggests satisfactory profitability and decent utilization of shareholders' equity.

ROA 1/2

The stock's ROA (1.06%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

PBV 1/2

The stock's PBV ratio (1.84x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

DER 0/2

The company has a high debt to equity ratio (333%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

Revenue Growth 2/2

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

Net Profit Growth 0/2

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

Assets Growth 1/2

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

Graham Number 0/1

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

Dividend Growth 0/2

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

Dividend 0/2

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

Buffet Intrinsic Value 1/1

The company's stock presents an enticing opportunity as it appears undervalued (3.291) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Ramsay Generale De Sante stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ramsay Generale De Sante

Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. It provides preventive care, primary medicine, medicine surgery obstetrics, oncology, medical imaging, medical care and rehabilitation, home hospitalization, mental health care and addiction treatment, geriatrics, tele monitoring and e health services; and operates medical centres, and mental health day care centres. The company was formerly known as Générale de Santé SA…

Full company profile